This Penny Healthcare Stock Under Rs. 30, engaged in providing technology-driven solutions and services primarily in the Life Sciences and Supply Chain Management sectors, including clinical research, generics support, regulatory filings, and pharmacovigilance, hit a 5 percent upper circuit after the company reported September quarterly results.
With a market capitalization of Rs. 406.23 crores, the shares of Take Solutions Limited hit a 5 percent upper circuit of Rs. 27.46 per share on Thursday, up from its previous closing price of Rs. 26.16 per share.
Currently, the stock has been trading at a 52-week high of Rs. 27.46 per equity share. Over the last one year and six months, the stock has delivered impressive returns of 60.21 percent and 241.12 percent, respectively.
Q2 FY26 Result Walkthrough
On October 27, 2025, Take Solutions Limited announced its quarterly results. The company reported no revenue from operations in Q2 FY26, remaining unchanged from Q2 FY25. However, it had generated Rs. 0.04 crore in revenue during Q1 FY26, indicating minimal operational activity in the September quarter.
In the second quarter of FY26, Take Solutions Limited has reported a consolidated net profit of Rs. 6.29 crore, a significant turnaround from a net loss of Rs. 1.58 crore in the same period last year. Additionally, compared to the first quarter of FY26, the company’s net profit has improved, shifting from a net loss of Rs. 0.91 crore to a positive figure.
In Q2 FY26, Take Solutions Limited achieved a net profit primarily due to the profits from discontinued operations of its wholly owned subsidiary, Ecron Acunova Limited (“EAL”).
In terms of return ratios, the company’s ROCE and ROE stand at 21.32 percent and 15.55 percent, respectively. Take Solutions Limited has an earnings per share (EPS TTM) of Rs. 0.27, and it’s a debt-free company.
Company Overview
Take Solutions Limited was established in 2000 and is headquartered in Chennai. The company is a global technology company specializing in Life Sciences and Supply Chain Management domains. The company leverages domain expertise and innovative technology to provide comprehensive clinical, regulatory, safety, and supply chain solutions to clients.
Take Solutions’ business included full-service Clinical Research Organization (CRO) services including clinical trials, bioavailability and bioequivalence studies, regulatory filing support, and pharmacovigilance. In the supply chain space, it focuses on engineering services, supply chain collaboration, product re-engineering, and automating supply chain processes through its IP-led technology platform.
The company serves a global client base comprising pharmaceutical, biotech, medical device manufacturers, and generics companies. Its operations span India, the USA, Europe, and other international markets, supported by domain excellence and global delivery centers.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
